Retatrutide is referred to as a triple G tri-agonist or triple hormone drug as it works at three different receptors
Our mission is to empower customers with reliable products and clear educational content, supported by a U.S.-based team that provides real human assistance and secure, senior-friendly payment options
You should contact your GP or healthcare professional if you experience: Heavy bleeding (soaking through a pad or tampon every hour for several consecutive hours) or passing large clots Prolonged bleeding lasting more than seven days or bleeding that does not stop Severe pelvic or abdominal pain that is new, persistent, or worsening Postmenopausal bleeding (any vaginal bleeding occurring 12 months or more after your last period) this requires an urgent 2-week suspected cancer referral [11] Bleeding between periods that is recurrent, increasing in frequency, or accompanied by other concerning symptoms Signs of anaemia , such as extreme fatigue, dizziness, shortness of breath, or pale skin It is also important to seek advice if you have missed periods and there is any possibility of pregnancy
Retatrutide, which Eli Lilly is also developing as an obesity drug, is considered a triple hormone receptor agonist
A: Research-grade AOD-9604 should be at least 98% pure, confirmed by HPLC (High-Performance Liquid Chromatography) analysis
